The analysis of consumption of intestinal anti-inflammatory agents in different countries of the world
Journal Title: Соціальна фармація в охороні здоров’я - Year 2019, Vol 5, Issue 2
Abstract
Aim. To assess drug consumption of the group A07E “Intestinal anti-inflammatory agents” in Ukraine and European countries in 2015-2017. Materials and methods. Data from the “Pharmexplorer” information system of Morion company were used to analyze the assortment and the consumption volumes of intestinal anti-inflammatory agents in Ukraine. The volumes, structure and dynamics of drug consumption of this group in Ukraine was assessed based on the number of the consumed defined daily doses (DDD) of drugs using the ATC/DDD methodology and the number of packs sold. The level of consumption of the drugs studied by the indicator “DDDs/1000 inhabitants/day” in the countries of Europe was determined by the statistical data of these countries. Results. The intestinal anti-inflammatory agents were presented in Ukraine in 2015-2017 in the number of 4 international non-patented names, 22-27 trade names (TN), mainly of foreign production with a high price for a pack. The number of TNs of drugs of this group and volumes of their consumption (by the number of packs sold and the number of the consumed DDDs) increased in Ukraine from 2015 to 2017. The largest number of packs sold was determined for sulfasalazine. The level of consumption of intestinal anti-inflammatory agents by the indicator “DDDs/1000 inhabitants/day” in Ukraine did not correspond to the level of drug consumption of this group in European countries (Norway, Lithuania, Latvia, Estonia) in 2015-2017, and it was the lowest among the countries studied. The largest volumes of drug consumption of this group were determined in Norway. Mesalazine was ranked first by the number of the consumed DDDs in Norway, Lithuania and Estonia in 2015-2017, and sulfasalazine – in Latvia. The leadership of sulfasalazine and mesalazine varied over the years in Ukraine. Conclusions. The volumes of drug consumption of the group A07E “Intestinal anti-inflammatory agents” by the number of packs sold and the number of the consumed DDDs increased in Ukraine from 2015 to 2017. The level of drug consumption of this group by the indicator “DDDs/1000 inhabitants/day” in Ukraine during 2015-2017 did not correspond to the level of consumption of the intestinal anti-inflammatory agents in European countries.
Authors and Affiliations
O. O. Gerasymova, L. V. Iakovlieva, V. O. Taran
Keywords
Related Articles
- EP ID EP663113
- DOI 10.24959/sphhcj.19.151
- Views 166
- Downloads 0
Ecopharmacy – a new interdisciplinary direction. Methodology. Development prospects
Aim. To analyze the influence of pharmacy on human ecology and the environment, generalize and structurize the interactions and interrelations identified. Materials and methods. Methods of scientific analysis, in partic...
The study of the individual competencies of a modern leader in the pharmaceutical sector of healthcare
Aim. To study the individual competencies of a modern leader as the coordinator of the organizational system in the pharmaceutical sector of healthcare in the context of adaptive management of the organizational culture....
Анализ ассортимента, социально-экономической доступности и объемов потребления лекарственных средств группы нестероидных противовоспалительных средств на фармацевтическом рынке Украины
Нестероидные противовоспалительные средства (НПВС) широко используются в мире и в Украине. При хронических заболеваниях опорно-двигательного аппарата противовоспалительную и анальгетическую терапию необходимо проводить д...
The study of the quality characteristics for the choice of cardiological drugs of plant origin
Aim. To study the assessment of the nomenclature of medicinal products in order to make it possible to select drugs that are most often prescribed by doctors from the whole range of herbal drugs, as well as to identify t...
International mechanism to confront medical products falsification as a means to improve the quality of Ukrainian pharmacy
Aim. To develop recommendations for improving the countering of medical products falsification in Ukraine using the international mechanism to confront, which should lead to increasing the pharmacy. Results. The internat...